Kyle Anthony

1 week ago | etfexpress.com | Kyle Anthony |Beverly Chandler

There were nine new ETF offerings launched in the past week, each with a distinct value proposition for investors. Detailed below are the respective launches from each asset manager. BlackRock launched the iShares S&P 500 3% Capped ETF (Ticker: TOPC), which seeks to track the investment results of the S&P 500 3% Capped Index, which is composed of the S&P 500 companies, subject to a 3 per cent company weight cap.

2 weeks ago | etfexpress.com | Kyle Anthony

There were 33 new ETF offerings launched in the past week, each with a distinct value proposition for investors. Detailed below are the respective launches from each asset manager. Long Pond Capital launched the Long Pond Real Estate Select ETF (Ticker: LPRE), an actively managed solution that aims to achieve total return through investment in a high-conviction portfolio of public companies that derive the majority of their revenue from real estate-related activities.

3 weeks ago | etfexpress.com | Kyle Anthony |Beverly Chandler

There were 21 new ETF offerings launched in the past week, each with a distinct value proposition for investors. Detailed below are the respective launches from each asset manager. Hotchkis & Wiley launched the H&W SMID Cap Diversified Value Fund (Ticker: HWSM), a diversified portfolio that targets undervalued small- and mid-cap stocks that are often out of favour and/or underfollowed.

3 weeks ago | benzinga.com | Kyle Anthony

With each generation, women's financial participation increases. As noted in Fidelity Investment's 2024 Women & Investing Study, 77% of Gen Z women and 74% of Millennial women are investing, versus 65% of Gen X women and 70% of Boomer women. Though the percentage differences between the demographic cohorts are noteworthy, what is most important is that women, overall, are increasing their participation in the financial markets.

4 weeks ago | benzinga.com | Kyle Anthony

When discussing cancer treatment, chemotherapy is usually among the first solutions that come to mind. However, its familiarity does not necessarily speak to its efficacy, as the treatment also damages healthy cells while killing cancerous ones. While there are differing treatment approaches for cancer, Vivos Inc.